✦ LIBER ✦

Optimizing the Clinical Benefit of Rituximab in Indolent Non-Hodgkin's Lymphoma

✍ Scribed by Gibson, Angelia D.; Jain, Vinay K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Introduction: Treatment of Patients With

✍ Stephanie A. Gregory 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 53 KB

PCN40 COST EFFECTIVENESS OF RITUXIMAB PL

✍ B Maturi; W Tong; M Gyldmark; J Creeden; R Aultman; FJ Jost 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Rituximab effective in non-Hodgkin’s lym

📂 Article 📅 1997 🏛 Adis International Limited (now part of Wolters Kl ⚖ 254 KB

The therapeutic use of rituximab in non-

✍ Robert Marcus; Anton Hagenbeek 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

Rituximab Improves Rate and Duration of

✍ Gibson, Angelia D.; Jain, Vinay K. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 94 KB

Lenalidomide plus rituximab can produce

✍ Tuscano, Joseph M.; Dutia, Mrinal; Chee, Karen; Brunson, Ann; Reed-Pease, Christ 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB